Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoller

Showing results (1221-1230 of 1,299) with videos related to

Pageof 130
Sort By:
Alimentary Pharmacology & Therapeutics|February 10, 2021
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosisStephan Buch, Aneesh Sharma, Eleanor Ryan, et al.
JHEP Reports : Innovation in Hepatology|June 19, 2025
Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosisLorenz Balcar, Malin Fromme, Naomi Kappe, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI RegistryUlrike Bauer, Maria R Troppmair, Najib Ben Khaled, et al.
The Journal of Investigative Dermatology|March 23, 2012
Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgarisOfer Sarig, Sivan Bercovici, Lilach Zoller, et al.
European Heart Journal|November 21, 2017
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromesRoland Klingenberg, Soheila Aghlmandi, Christoph Liebetrau, et al.
JCI Insight|February 8, 2019
Multimodal imaging guides surgical management in a preclinical spinal implant infection modelStephen D Zoller, Howard Y Park, Tove Olafsen, et al.
Hepatology Communications|June 14, 2023
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinomaMaria Effenberger, Silvio Waschina, Christina Bronowski, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancerLeslie Duplaquet, Kevin So, Alexander W Ying, et al.
Annals of Hepatology|February 13, 2022
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up studyStefano Gitto, Paolo Magistri, Luca Marzi, et al.
Journal of Medicinal Chemistry|August 24, 2018
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1Joseph Schoepfer, Wolfgang Jahnke, Giuliano Berellini, et al.
Pageof 130

Showing results (1221-1230 of 1,299) with videos related to

Sort By:
Pageof 130
Alimentary Pharmacology & Therapeutics|February 10, 2021
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosisStephan Buch, Aneesh Sharma, Eleanor Ryan, et al.
JHEP Reports : Innovation in Hepatology|June 19, 2025
Severe alpha-1 antitrypsin deficiency is associated with a higher risk of complications after first decompensation than other aetiologies of cirrhosisLorenz Balcar, Malin Fromme, Naomi Kappe, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2026
Liver Transplantation After Immune Checkpoint Inhibition in Hepatocellular Carcinoma-Data From the Multinational LITCHI RegistryUlrike Bauer, Maria R Troppmair, Najib Ben Khaled, et al.
The Journal of Investigative Dermatology|March 23, 2012
Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgarisOfer Sarig, Sivan Bercovici, Lilach Zoller, et al.
European Heart Journal|November 21, 2017
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromesRoland Klingenberg, Soheila Aghlmandi, Christoph Liebetrau, et al.
JCI Insight|February 8, 2019
Multimodal imaging guides surgical management in a preclinical spinal implant infection modelStephen D Zoller, Howard Y Park, Tove Olafsen, et al.
Hepatology Communications|June 14, 2023
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinomaMaria Effenberger, Silvio Waschina, Christina Bronowski, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancerLeslie Duplaquet, Kevin So, Alexander W Ying, et al.
Annals of Hepatology|February 13, 2022
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up studyStefano Gitto, Paolo Magistri, Luca Marzi, et al.
Journal of Medicinal Chemistry|August 24, 2018
Discovery of Asciminib (ABL001), an Allosteric Inhibitor of the Tyrosine Kinase Activity of BCR-ABL1Joseph Schoepfer, Wolfgang Jahnke, Giuliano Berellini, et al.
Pageof 130